FindTrial
Sign In

4 microRNAs detection kit (fluorescence probe PCR method)

Clinical assessment of a panel of four miRNAs in detection of pancreatic cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077479
Enrollment
Unknown
Registered
2023-11-09
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Gold Standard:According to Diagnosis and Treatment Criteria of Pancreatic Cancer (2018), histopathological or cytological examination can determine the diagnosis of pancreatic cancer through preoperat
Index test:4 microRNAs detection kit (fluorescence probe PCR method)

Sponsors

Beijing Union Medical College Hospital of the Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Aged =18 years old, gender unlimited; (2) Serum samples from individuals who meet the requirements of the case group/non-case group; (3) The minimum requirement of serum volume is 1 mL; (4) Subjects met the hospital’s informed consent process or voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Samples with insufficient serum; (2) Hemolytic sample; (3) Storage, transportation, treatment, and other samples that do not meet the requirements; (4) Multiple samples of the same subject; (5) Other situations that the researcher believes need to be excluded.

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;—

Countries

China

Contacts

Public ContactJunchao Guo

Beijing Union Medical College Hospital of the Chinese Academy of Medical Sciences

gjcpumch@163.com+86 136 0124 8088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026